E-mail:gzliang@cqu.edu.cn    Tel: (86)2365102507

List of peptide properties
DFBP ID - DFBPDPIV0046(DPP IV-inhibitory peptide)
DFBP ID DFBPDPIV0046
Peptide sequence IPAVFK
Type Native peptide
Peptide/Function name DPP-IV inhibitory peptide, Anti-diabetic peptide
Function-activity relationship
Main bioactivity DPP-IV inhibitory activity
Otheir bioactivity ACE-inhibitory activity [D1], Antioxidative activity [D2], Antimicrobial activity [D3], Multifunctional activity [D4]
Calculated physicochemical properties
Three-letter amino acid Ile-Pro-Ala-Val-Phe-Lys
Single-letter amino acid IPAVFK
Peptide length 6
Peptide mass
Experimental mass Theoretical mass
N.D 673.84 Da c
Net charge 0.00 c
Isoelectric point (pI) 10.04 c
IC50 N.D
pIC50 N.D
GRAVY 1.3000 c
Hydrophilic residue ratio 83.33% c
Peptide calculator
To calculate the physicochemical properties of bioactive peptide.
Peptide source & Food-borne protein(s) search
Classification Animal
Organism/Source Bovine whey protein
Precursor protein β-Lactoglobulin
Residue position

f(78-83)

Precursor protein(s) search
Link-research
There are no literature reports on the discovery of this sequence in other food-source proteins.
Biological/Functional activity & target protein
DPP IV-inhibitory activity

(1) Inhibitor of Dipeptidyl-peptidase IV (EC 3.4.14.5). The peptide IPAVFK showed notable DPP-IV inhibitory activity with the IC50 value of 143.0 μM, lower than IPAVF (44.7 μM).
(2) The IC50 value was 149.1 ± 17.0 μM [1].

Specific target protein(s) Specific Target Protein(s):
Dipeptidyl peptidase 4
Taste properties & Structure
Bitterness
Literature report N.D
Bitter prediction tools Bitter taste prediction
SMILES N[C@@]([H])([C@]([H])(CC)C)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(CCCCN)C(=O)O
Preparation method
Mode of preparation

Enzymatic hydrolysis

Enzyme(s)/starter culture

The whey protein concentrate rich in β-lactoglobulin was hydrolysed with trypsin and the trypsin was added at an enzyme-to-substrate ratio of 1:20 (w/w) and hydrolysis was carried out at 37 ℃ for 3 h with constant agitation.

Stability & Cytotoxicity
Peptide stability
Literature report: N.D
EHP-Tool: Enzymatic Hydrolysis Prediction Tool (EHP-Tool)
Peptide cytotoxicity
Literature report: N.D
Prediction: ToxinPred
Additional information
Additional information

β-Lactoglobulin derived peptides may form part of a functional food based dietary strategy for the management of CVD and T2DM [1].

Database cross-references
DFBP
[D1] DFBPACEI0645
[D2] DFBPANOX0700
[D3] DFBPAMIC0338
[D4] DFBPMUFU0443
BIOPEP-UWM [D5] 8196, 8621, 9232
APD [D6] -
BioPepDB [D7] -
MBPDB [D8] -
Reference(s)
Primary literature Silveira ST, Martínez-Maqueda D, Recio I, Hernández-Ledesma B. Dipeptidyl peptidase-IV inhibitory peptides generated by tryptic hydrolysis of a whey protein concentrate rich in β-lactoglobulin. Food Chem. 2013 Nov 15;141(2):1072-7.
PMID: 23790888
Other literature(s)

[1] Power O, Fernández A, Norris R, et al. Selective enrichment of bioactive properties during ultrafiltration of a tryptic digest of β-lactoglobulin[J]. Journal of Functional Foods, 2014, 9:38-47.

PubDate 2013
Copyright © 2020. Record / license number: Chongqing ICP No. 2000214